Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $51.09 USD
Change Today +0.58 / 1.15%
Volume 941.7K
PKI On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

perkinelmer inc (PKI) Snapshot

Open
$50.56
Previous Close
$50.51
Day High
$51.18
Day Low
$50.44
52 Week High
03/27/15 - $51.18
52 Week Low
10/15/14 - $38.96
Market Cap
5.8B
Average Volume 10 Days
1.4M
EPS TTM
$1.56
Shares Outstanding
113.1M
EX-Date
04/15/15
P/E TM
32.7x
Dividend
$0.28
Dividend Yield
0.55%
Current Stock Chart for PERKINELMER INC (PKI)

perkinelmer inc (PKI) Related Businessweek News

No Related Businessweek News Found

perkinelmer inc (PKI) Details

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerate the discovery and development of critical new therapies. It provides early detection for genetic disorders from pregnancy to early childhood, well as flat panel X-ray detectors and infectious disease testing for the diagnostics market; and a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. This segment’s research portfolio includes instrumentation for automation and detection solutions, and in vitro and in vivo imaging and analysis hardware and software; and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides products, services, and solutions to facilitate the creation of safer food and consumer products. It develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, soil, and food. This segment also provides analytical instrumentation for the industrial market, which includes the chemical, petrochemical, lubricant, polymer, electronics, pharmaceutical, and food and dietary supplement industries; and laboratory services. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

7,700 Employees
Last Reported Date: 02/24/15
Founded in 1931

perkinelmer inc (PKI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $1.0M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $492.3K
Senior Vice President and President of Enviro...
Total Annual Compensation: $400.0K
Senior Vice President and President of Human ...
Total Annual Compensation: $383.1K
Senior Vice President of Administration, Gene...
Total Annual Compensation: $410.4K
Compensation as of Fiscal Year 2014.

perkinelmer inc (PKI) Key Developments

PerkinElmer Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 09:00 AM

PerkinElmer Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 09:00 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Robert F. Friel, Chairman, Chief Executive Officer, President and Member of Finance Committee.

PerkinElmer Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 09:20 AM

PerkinElmer Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 09:20 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Frank A. Wilson, Chief Financial Officer and Senior Vice President.

PerkinElmer Inc. Elects Sylvie Grégoire to its Board of Directors

PerkinElmer Inc. announced that Sylvie Grégoire, Pharm. D., has been elected to its Board of Directors, effective February 6, 2015. With nearly 30 years of industry experience, Dr. Grégoire most recently served as President of Human Genetic Therapies for Shire Plc for seven years. Dr. Grégoire is currently a Board member of Galenica Limited and also served for five years on the Board of Cubist Pharmaceuticals.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PKI:US $51.09 USD +0.58

PKI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr214.70 SEK +4.10
MEDNAX Inc $72.11 USD +0.13
QIAGEN NV €23.15 EUR +0.378
Sirona Dental Systems Inc $88.76 USD +0.68
Teleflex Inc $119.89 USD +0.74
View Industry Companies
 

Industry Analysis

PKI

Industry Average

Valuation PKI Industry Range
Price/Earnings 36.1x
Price/Sales 2.6x
Price/Book 2.8x
Price/Cash Flow 36.6x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERKINELMER INC, please visit www.perkinelmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.